Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.17)
# 3,786
Out of 5,127 analysts
28
Total ratings
26.67%
Success rate
-7.47%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOS The Mosaic Company | Maintains: Neutral | $26 → $24 | $26.48 | -9.37% | 8 | Dec 5, 2025 | |
| EMN Eastman Chemical Company | Downgrades: Neutral | $112 → $76 | $68.78 | +10.50% | 8 | Apr 28, 2025 | |
| ECL Ecolab | Downgrades: Neutral | $200 → $220 | $271.74 | -19.04% | 5 | Feb 14, 2024 | |
| LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $47.64 | +109.91% | 3 | Feb 5, 2024 | |
| AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $186.02 | +17.19% | 2 | Feb 1, 2024 | |
| LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $1,085.19 | -85.53% | 2 | Aug 14, 2020 |
The Mosaic Company
Dec 5, 2025
Maintains: Neutral
Price Target: $26 → $24
Current: $26.48
Upside: -9.37%
Eastman Chemical Company
Apr 28, 2025
Downgrades: Neutral
Price Target: $112 → $76
Current: $68.78
Upside: +10.50%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $271.74
Upside: -19.04%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $47.64
Upside: +109.91%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $186.02
Upside: +17.19%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $1,085.19
Upside: -85.53%